Find uplifting stories about heroes, innovations, and solutions
10465 results for "vision treatment"
After losing her husband and facing a blinding eye disease, 73-year-old Cathy refused to let geographic atrophy dim her spark. She found a treatment that's slowing her vision loss and rediscovered her independence through piano, sewing, and small daily joys.
A New Orleans patient became the first in Louisiana to receive a breakthrough melanoma treatment that saves their eye, eliminating the need for removal or distant travel. The procedure offers new hope for eye cancer patients across the Gulf Coast.
Scientists discovered that separate technologies developed over 50 years to restore sight and touch actually work nearly the same way. This breakthrough could fast-track treatments for patients with untreatable vision loss and paralysis.
A single injection of experimental drug Axpaxli kept vision stable for up to a year in patients with age-related blindness, potentially reducing treatment burden. The Phase 3 trial showed significantly better durability than the current standard treatment.
Scientists at Duke University used stem cells to grow specialized retinal blood vessel cells that restored vision in blind mice. The breakthrough could lead to affordable treatments for millions facing vision loss from diseases like diabetic retinopathy.
Researchers at University of Rochester Medicine received NIH funding to develop a breakthrough treatment that could stop macular degeneration before it steals vision from millions of older adults. The new therapy targets a protein that drives the disease at its earliest stages.
Scientists in Finland developed a gentle heat treatment that helps aging eyes repair themselves before dry macular degeneration causes vision loss. Human trials begin this spring for a condition affecting 20 million Americans.
Scientists have discovered breakthrough ways to slow nearsightedness in kids, potentially preventing blindness for millions. Simple lifestyle changes and new treatments could protect a generation of children from severe vision loss.
Scientists in Finland developed a gentle heat treatment that activates the eye's natural repair systems before dry macular degeneration causes vision loss. Human trials start this spring for a condition affecting 20 million Americans over 40.
Scientists at Duke University grew specialized retinal blood vessel cells from stem cells and successfully used them to restore vision in mice with damaged retinas. The breakthrough could lead to new treatments for millions suffering from diabetic retinopathy and other causes of blindness.
A Belgian startup just earned FDA breakthrough status for a brain implant that bypasses damaged eyes entirely to restore functional vision. Clinical trials in blind volunteers could begin as soon as summer 2027.
A person with glaucoma just became the first to receive an experimental treatment that regenerates damaged nerves by reprogramming cells to a younger state. If successful, this approach could eventually reverse other age-related diseases beyond vision loss.
Scientists have treated the first person with a groundbreaking gene therapy that makes old cells act young again, aiming to restore vision lost to glaucoma. This marks the beginning of testing whether cellular rejuvenation can safely treat human disease.
A New Jersey high school senior who endured childhood eye surgeries and delayed treatment has won a $20,000 Coca-Cola scholarship after founding a nonprofit to help other low-income children access vision care. Brandon Delcid Rios was selected from over 107,000 applicants nationwide.
Scientists have created a wireless retinal implant thinner than a human hair that could one day restore sight to millions living with vision loss. The breakthrough device uses safe near-infrared light instead of risky visible light, eliminating the need for bulky electronics.
Researchers discovered a simple fatty acid injection that restores vision in older mice by targeting an aging gene. The breakthrough could help millions facing age-related vision loss and macular degeneration.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Scientists developed a gene therapy that could reduce painful monthly eye injections for macular degeneration patients down to just once or twice a year. The breakthrough offers hope to nearly 20 million Americans battling the leading cause of vision loss in older adults.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
Showing 20 of 10465